Southwest Research Institute

Southwest Research, Texas Biomedical awarded $3.4M for Ebola countermeasure

Wednesday, June 8, 2016

Southwest Research Institute (SwRI) has announced a one-year, $3.4 million contract award from the Defense Threat Reduction Agency (DTRA) to combine two available medications and test the resulting combination drug therapy against the Ebola virus. SwRI is collaborating with Texas Biomedical Research Institute on this program. The award is a one-year contract with two additional option years.

[Read More]

BARDA awards SwRI $8.3M to continue developing cyanide poisoning antidote

Wednesday, March 26, 2014

The U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) has awarded Southwest Research Institute (SwRI), an independent, nonprofit, applied R&D organization, an $8.3 million contract extension to continue development of a nasal-delivery, first-line treatment system to combat cyanide poisoning using an intranasal formulation of isoamyl nitrite.

[Read More]